Research Topics
| Marc BrissonSummaryCountry: Canada Publications
| Collaborators
|
Detail Information
Publications
Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccinationMelanie Drolet
Centre de recherche du CHU de Québec Hôpital Saint Sacrement, 1050 Chemin Sainte Foy, Quebec G1S 4L8, Canada
Cancer Epidemiol Biomarkers Prev 22:641-52. 2013..We aim to identify the sociodemographic characteristics of women who reported greater sexual activity and/or screening underuse...- Different population-level vaccination effectiveness for HPV types 16, 18, 6 and 11Marc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
Sex Transm Infect 87:41-3. 2011..Given that the human papillomavirus (HPV) vaccine types have different durations of infectiousness and infectivity, the population-level vaccine effectiveness of these types may differ even if vaccine efficacy is identical... - Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zosterMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
Vaccine 28:3385-97. 2010..Adding a 2-dose program may help guarantee high population-level effectiveness against varicella. However, the incremental benefit of a second dose is highly dependant on the effectiveness of the first dose and its impact on zoster... - Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective studyMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, QC, Canada
Pediatr Infect Dis J 29:73-5. 2010..Our results show that RGE impacts the health-related quality of life of children and parents adversely... - Economic evaluation of human papillomavirus vaccination in developed countriesMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que, Canada
Public Health Genomics 12:343-51. 2009..The demand for modeling has resulted in the publication of numerous mathematical models looking at the cost-effectiveness of HPV vaccination... 
Estimating the number needed to vaccinate to prevent herpes zoster-related disease, health care resource use and mortalityMarc Brisson
Départemente de médecine sociale et préventive, Universite Laval, Quebec, QC
Can J Public Health 99:383-6. 2008..The aim of the study was to estimate the number needed to vaccinate (NNV) to prevent HZ-related outcomes...- The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgiaMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, Canada
Hum Vaccin 4:238-45. 2008..In conclusion, results suggest that vaccinating adults between the ages of 65 and 75 years is likely to be cost-effective and thus to be a judicious use of scarce health care resources... - Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunityMarc Brisson
Unité de recherche en santé des populations, Centre de recherche Fonds de la recherche en santé du Québec du Centre hospitalier affilié universitaire de Québec, Canada
J Infect Dis 204:372-6. 2011..Given the important predicted herd immunity impact of vaccinating girls under moderate to high vaccine coverage, the potential incremental gains of vaccinating boys are limited... 
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infectionMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Quebec, Que
CMAJ 177:464-8. 2007..A vaccine against human papillomavirus (HPV) types 6, 11, 16 and 18 is now licensed for use in Canada and many other countries. We sought to estimate the number needed to vaccinate to prevent HPV-related diseases and death...- The potential cost-effectiveness of prophylactic human papillomavirus vaccines in CanadaMarc Brisson
Departement de Medecine sociale et preventive, Universite Laval, Que, Canada
Vaccine 25:5399-408. 2007..Clinical trials have shown prophylactic human papillomavirus (HPV) vaccines to be effective against infection and disease. We examined whether HPV vaccination has the potential to be cost-effective... - The psychosocial impact of an abnormal cervical smear resultMelanie Drolet
URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec City, Quebec, Canada
Psychooncology 21:1071-81. 2012.... - Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resourcesAtika Benbernou
Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Canada
Eur J Pain 15:1100-6. 2011..Herpes zoster results from the reactivation of the varicella-zoster virus, which is often accompanied by a prodrome of dermatomal pain. Little is known about the burden of prodromal pain... - Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysisNicolas Van de Velde
Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Canada
J Natl Cancer Inst 104:1712-23. 2012..Furthermore, clinical trials examining the efficacy of a nonavalent vaccine are underway. We aimed to compare the potential population-level effectiveness of the bivalent, quadrivalent, and candidate nonavalent HPV vaccines... - Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective studyMelanie Drolet
URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, QC, Canada
J Pain 11:1211-21. 2010..Despite the high proportion of subjects treated with antivirals, the burden of PHN remains considerable, suggesting that prevention and additional early interventions are needed to reduce the burden of HZ... - A prospective study of the herpes zoster severity of illnessMelanie Drolet
Centre Hospitalier Affilie Universitaire De Quebec, Hôpital Saint Sacrement, Quebec, QC, Canada
Clin J Pain 26:656-66. 2010.... - Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective studyMelanie Drolet
URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, QC, Canada
Vaccine 30:2047-50. 2012..These results provide new information about the burden of HZ and PHN, which is useful for public health planning and cost-effectiveness analyses of HZ vaccination among individuals of working age... - The impact of anogenital warts on health-related quality of life: a 6-month prospective studyMelanie Drolet
URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec, Quebec, Quebec, Canada
Sex Transm Dis 38:949-56. 2011..We conducted a multicenter prospective study to (1) describe the impact of anogenital warts on quality of life and (2) estimate the quality-adjusted life-years (QALYs) lost due to anogenital warts... - Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertaintyNicolas Van de Velde
Department of Social and Preventive Medicine, Laval University, Quebec, Canada
Am J Epidemiol 165:762-75. 2007..Important priorities for future research are to understand the role of natural immunity and to measure the duration of vaccine protection because results were most sensitive to these parameters... - Loss of quality of life associated with genital warts: baseline analyses from a prospective studyMartin Senecal
Merck Frosst Canada Ltd, Montreal, Quebec, Canada
Sex Transm Infect 87:209-15. 2011..The findings are described in terms that are more specific to individuals with genital warts using psychosocial questions adapted from the HPV impact profile, a measure developed for HPV-related conditions... - The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective studyMelanie Drolet
Unité de recherche en santé des populations, Centre Hospitalier Affilie Universitaire De Quebec, Quebec, Que
CMAJ 182:1731-6. 2010..Vaccination against herpes zoster is being considered in many countries. We conducted a multicentre prospective study to describe the impact of herpes zoster and postherpetic neuralgia on health-related quality of life... - The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: a model-based analysisTalía Malagón
Centre de Recherche du CHU de Québec, Quebec, Canada
Vaccine 31:1740-7. 2013..Our aim was to illustrate how differential HPV vaccine uptake by sexual behaviour can impact population-level vaccination effectiveness and inequalities in HPV prevalence... - Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysisTalía Malagón
Unité de Recherche en Santé des Populations URESP, Centre de Recherche Fonds de la Recherche en Santé du Québec FRSQ du Centre Hospitalier Affilié Universitaire de Québec CHA, Quebec, Canada
Lancet Infect Dis 12:781-9. 2012.... - Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysisNicolas Van de Velde
Departement de Medecine sociale et preventive, Universite Laval, Quebec, QC, Canada
Vaccine 28:5473-84. 2010.... - Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgiaMarc Brisson
Clin Infect Dis 45:1527-9. 2007 - Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsJames M Pellissier
Merck Research Laboratories, Blue Bell, PA, United States
Vaccine 25:8326-37. 2007..s.)... - A cost-utility analysis of losartan versus atenolol in the treatment of hypertension with left ventricular hypertrophyAslam H Anis
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada
Pharmacoeconomics 24:387-400. 2006..Incorporating the results found in the LIFE study into an economic model, an incremental cost-effectiveness analysis was performed comparing losartan with atenolol in the treatment of 67-year old patients with hypertension and LVH... - An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasiaHeather McDonald
Innovus Research Inc, Burlington, Ontario, Canada
Can J Urol 11:2327-40. 2004..The cost-effectiveness of combination therapy increases as serum PSA level increases... - The potential cost-effectiveness of acellular pertussis booster vaccination in England and WalesW John Edmunds
Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Collindale Avenue, NW9 5EQ, London, UK
Vaccine 20:1316-30. 2002..Significant uncertainty remains regarding the epidemiology of pertussis and the impact of booster doses. Nevertheless, the introduction of acellular boosters, particularly at 4 years, has the potential to be cost-effective in the UK...